NIH Rigor • Clinical Trial Protocols • Global Health Impact

Medical Grant Writing Services for Principal Investigators & Clinical Consortia

Secure competitive biomedical and global health research funding. We formulate high-scoring NIH (R01/R21/K-series), Wellcome Trust, EDCTP, and Grand Challenges Africa grant proposals, clinical trial protocols, Specific Aims pages, and dual-layer bioethics (NHREC/IRB) documentation across Nigeria, Pan-Africa, and international research corridors.

Top 12%
NIH Study Section Percentile Benchmark
100%
Zero-Currency Bespoke Scoping Standard
100% Defensible
NHREC & NAFDAC Bioethics Compliance
24+ Hubs
Pan-African Clinical Research Presence
01 Epidemiological Foundation Specific Aims & Health Gap Burden of Disease & DALYs Mechanistic Central Hypotheses 1-Page Specific Aims Standard Scientific Premise 02 Biostatistical & Trial Rigor Power, RCTs & Protocols Statistical Power & Sample Size Primary & Secondary Endpoints DSMB & Interim Stopping Rules Methodological Bulletproof 03 Governance & Bioethics NHREC, IRB & NAFDAC Dual-Layer IRB/NHREC Dossiers Material Transfer Agreements (MTA) Culturally Adapted ICFs & CAB Ethical Defensibility 04 Reviewer Scoring & Award Study Section Defense NIH CSR Study Section Rubric F&A / NICRA Budget Justification Summary Statement Pink Sheets Fundable Impact Priority
Bespoke Institutional Scoping Standard

Structured Advisory Engagements • Zero Generic Tariffs

Every medical research grant represents a distinct epidemiological mandate, investigator consortium, and clinical funding mechanism. We do not publish standardized price tags; instead, we deploy tailored diagnostic sprints and institutional retainers designed to maximize reviewer percentile ranking.

Diagnostic Sprint Scope • 14-Day Delivery SLA

Exploratory Pilot & Specific Aims Sprint

Tailored for early-career clinical investigators, university lecturers, and specialty medical fellows requiring a bulletproof 1-page Specific Aims document, funding mechanism match, and hypothesis deconstruction.

Diagnostic Sprint Scope • 14-Day Delivery SLA
  • Rigorous deconstruction of scientific premise, mechanistic hypothesis, and research aims
  • Drafting of high-impact 1-page Specific Aims matching NIH/Wellcome reviewer rubric
  • Funder alignment diagnostic (NIH R21/K-series, Wellcome Early-Career, EDCTP, or AAS)
  • Preliminary biostatistical sample size and primary endpoint alignment review
  • Investigator Biosketch (NIH format) review and contribution-to-science optimization
  • 14-day rapid delivery sprint with two iterative review cycles with senior medical grant writers
Commission Specific Aims Sprint
Institutional Program • Bespoke Enterprise Retainer

Global Health Institutional Excellence & Defense Suite

Engineered for university faculties of medicine, national research institutes, biopharma ventures, and multi-country African consortia submitting multi-million-dollar program grants and clinical trial networks.

Institutional Program • Bespoke Enterprise Retainer
  • End-to-end institutional proposal drafting for P01/U01 cooperative agreements or major Gates/Wellcome hubs
  • Full Clinical Protocol Development conforming to ICH-GCP, WHO, and NHREC guidelines
  • Multi-country ethical approval roadmaps, Material Transfer Agreements (MTA), and regulatory dossiers
  • Direct collaboration with Dean of Medicine, Hospital Research Board, and Consortium PIs
  • Panel interview defense coaching, visual slide pack design, and mock reviewer cross-examination
  • Resubmission pink-sheet deconstruction and response-to-reviewers strategy matrices
  • Institutional capacity-building workshops for departmental clinical investigator teams
Commission Institutional Program
Rigorous Protocol Architecture

Our 5-Stage Grant Engineering Methodology

A proven, peer-reviewed clinical writing sequence designed to eliminate reviewer objections, prove mechanistic causality, and deliver fundable proposals.

01

Epidemiological Hypothesis

We analyze your clinical premise against specific Notice of Special Interest (NOSI) directives, funder strategic priorities, and African burden-of-disease realities.

02

Specific Aims Modeling

We engineer a compelling 1-page Specific Aims narrative with distinct, non-interdependent aims, clear mechanistic hypotheses, and measurable clinical outcomes.

03

Biostatistics & Ethics

Our epidemiology specialists integrate rigorous sample size justifications, randomization protocols, NHREC/IRB compliance, and Data Safety Monitoring Plans.

04

Mock Study Section

We subject the proposal to blind peer-review scoring against funder criteria (Significance, Innovation, Approach, Investigators, Environment) to eliminate pitfalls.

05

Dossier Packaging

We finalize complete SF424 or funder-specific packages, including modular budgets, equipment sheets, consortium letters of support, and formatted biosketches.

Authoritative Scientific Foundation

Empirical Governance & Institutional Benchmarks

Every medical grant written by Writely.ng is grounded in internationally recognized health research directives and statutory bioethics frameworks.

National Institutes of Health (NIH)
Center for Scientific Review (CSR) & SF424 (R&R) Rigor and Reproducibility Application Guidelines
The premier global benchmark governing peer-review criteria (Significance, Investigators, Innovation, Approach, Environment), clinical trial specific aims, and rigorous scientific premise standards.
Review NIH Grant Guidelines →
Wellcome Trust & EDCTP
European & Developing Countries Clinical Trials Partnership (EDCTP) & Global Health Research Framework
International standards mandating equitable North-South research partnerships, capacity strengthening, open-access clinical data sharing, and robust governance in African disease research.
Explore Wellcome Research Directives →
World Health Organization (WHO) & CIOMS
International Ethical Guidelines for Health-related Research Involving Humans & Clinical Trial Standards
Universal bioethical principles requiring rigorous institutional review board (IRB) oversight, vulnerable population protection, fair participant compensation, and post-trial access.
Access WHO/CIOMS Bioethics Standards →
National Health Research Ethics Committee of Nigeria (NHREC) & NAFDAC
Operational Guidelines for Health Research Ethics & NAFDAC Clinical Trial Authorization Framework
Statutory Nigerian regulations governing clinical trial ethical approval, biological material transfer agreements (MTA), Good Clinical Practice (GCP) compliance, and trial registry.
Read NHREC Nigerian Ethics Regulations →
African Academy of Sciences (AAS) & Science for Africa Foundation
Grand Challenges Africa & Developing Excellence in Leadership, Training, and Science (DELTAS Africa)
Pan-African scientific framework establishing competitive evaluation metrics, indigenous health research priority setting, and institutional multi-country consortium leadership.
Explore AAS Grand Challenges Africa →
Integrated Academic & Corporate Writing Suite

Interdisciplinary Research & Technical Capabilities

Medical grants intersect with biostatistics, epidemiology, corporate tax governance, and research communications. Explore related professional writing disciplines on Writely.ng.

Clinical Research Footprint

Pan-African Network • Teaching Hospital Corridors

Our medical grant writing desk coordinates seamlessly across primary health research institutes, university teaching hospitals, and multicenter clinical trial hubs across Nigeria and the African continent.

Pan-African Research Centers & Operational Corridors

🇳🇬 Abuja, Nigeria
🇬🇭 Accra, Ghana
🇰🇪 Nairobi, Kenya
🇿🇦 Johannesburg, South Africa
🇷🇼 Kigali, Rwanda
🇪🇬 Cairo, Egypt
🇺🇬 Kampala, Uganda
🇹🇿 Dar es Salaam, Tanzania
🇸🇳 Dakar, Senegal
🇪🇹 Addis Ababa, Ethiopia
🇿🇲 Lusaka, Zambia
🇨🇲 Yaoundé, Cameroon

Nigerian Academic Health Centers & Clinical Corridors

📍 Ibadan (UCH / UI)
📍 Lagos (LUTH / CMUL)
📍 Zaria (ABUTH / ABU)
📍 Enugu (UNTH / UNN)
📍 Abuja (NHA / UATH)
📍 Benin City (UBTH / UNIBEN)
📍 Kano (AKTH / BUK)
📍 Jos (JUTH / UniJos)
📍 Port Harcourt (UPTH / UniPort)
📍 Ile-Ife (OAUTHC / OAU)
📍 Ilorin (UITH / Unilorin)
📍 Calabar (UCTH / UniCal)
Rigorous Answers for Investigators

Frequently Asked Medical Grant Questions

In-depth technical answers addressing NIH study sections, biostatistics, bioethics approvals, and consortium governance.

Q: How does Writely.ng ensure medical grant proposals achieve high reviewer scoring at NIH or Wellcome Trust?
Medical grant peer-review panels operate under intense time constraints and evaluate hundreds of dense applications. Reviewers typically decide an application's fate within the first two pages. At Writely.ng, we apply a proven 'reviewer-first' architecture. We structure the Specific Aims page to establish the urgent clinical health gap, the mechanistic hypothesis, our preliminary data foundation, and two to three logically distinct, non-interdependent aims. Every subsection in the Research Strategy directly addresses the five core NIH criteria: Significance, Investigators, Innovation, Approach, and Environment.
Q: Can your medical grant writers handle complex biostatistical power calculations and trial methodology?
Yes. Inadequate statistical power or vague analytical plans are the leading causes of grant triage. Our medical writing team includes biostatistical and epidemiological consultants who develop rigorous power calculations, effect size estimations, sample size attrition allowances, and detailed Statistical Analysis Plans (SAPs). We define explicit primary and secondary endpoints, covariate adjustments, missing-data handling (e.g., multiple imputation), and interim stopping boundaries for clinical efficacy and futility.
Q: How do you navigate international bioethics (IRB) and local Nigerian approvals (NHREC, NAFDAC)?
Cross-border medical research requires navigating strict dual-layer ethical frameworks. We draft comprehensive Human Subjects Protection narratives compliant with US 45 CFR 46 (Common Rule), Wellcome Trust governance, and the National Code for Health Research Ethics enforced by Nigeria's National Health Research Ethics Committee (NHREC). We assist with Clinical Trial Authorization (CTA) dossiers for NAFDAC, Material Transfer Agreements (MTAs) for biological sample export, and culturally sensitive Informed Consent Forms (ICFs).
Q: Do you assist with resubmissions, pink sheets, and Summary Statement responses?
Yes. Resubmissions (A1 applications) frequently achieve the highest funding success rates when reviewer criticisms are addressed constructively. We perform a forensic breakdown of your Summary Statement (pink sheet), categorizing critiques into addressable methodology adjustments, preliminary data additions, or text clarifications. We then draft the mandatory 1-page Introduction to Resubmission, demonstrating point-by-point responsiveness with professional academic tone.
Q: How do you structure budget justifications and indirect costs (F&A / NICRA)?
Funder budget scrutiny can lead to severe funding cuts or disqualification if costs are not meticulously justified. We formulate detailed, transparent modular and categorical budgets. We calculate personnel effort (person-months) according to institutional base salaries, justify consumables, laboratory reagents, field survey transport, patient travel stipends, and participant retention mechanisms. For African institutions with or without a federally negotiated indirect cost rate (NICRA), we apply the appropriate de minimis modified total direct cost (MTDC) rates in strict compliance with funder rules.
Q: What qualifications and clinical backgrounds do Writely.ng's medical grant writers possess?
Our specialized medical grant writing desk is staffed exclusively by doctoral-level biomedical researchers (PhDs), clinical physicians (MBBS/MD), and public health epidemiologists (MPH). Our writers have authored funded NIH, Wellcome, Gates, and EDCTP grant proposals, published in leading peer-reviewed journals (The Lancet, BMJ Global Health, Nature Medicine), and served on academic institutional review boards, ensuring your proposal is crafted with deep scientific credibility.

Advance Your Clinical Science. Secure Global Funding.

Do not let bureaucratic complexity or grant formatting flaws compromise groundbreaking biomedical discoveries. Partner with Africa's dedicated clinical and medical grant writing desk.